Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: Stepan Company produces specialty and intermediate chemicals sold to manufacturers for use in detergents, personal care products, plastics, building materials, and food/pharmaceutical applications. The Company operates three reportable segments: Surfactants (74% of 2007 sales), Polymers (24%), and Specialty Products (2%).
Key Financial Metrics
| Metric (in thousands) | 2007 | 2006 |
|---|---|---|
| Net Sales | $1,329,901 | $1,172,583 |
| Gross Profit | $141,396 | $125,786 |
| Operating Income | $35,095 | $15,853 |
| Net Income | $15,118 | $6,670 |
| Diluted EPS | $1.50 | $0.63 |
| Cash from Operations | $47,075 | $38,828 |
| Total Debt | $127,963 | $131,164 |
| Working Capital | $92,954 | $87,974 |
| Current Ratio | 1.5 | 1.5 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 13% ($157.3 million) driven by a 6% increase in average selling prices (pass-through of raw material costs), a 5% increase in sales volume, and favorable currency translation effects.
- Profitability Surge: Net income increased 127% to $15.1 million. Operating income rose 121% to $35.1 million, primarily due to improved gross profit ($15.6 million increase) and a $3.6 million decline in operating expenses.
- Segment Performance:
- Surfactants: Sales up 11%; Operating income up 40%.
- Polymers: Sales up 22%; Operating income up 7%.
- Specialty Products: Sales up 17%; Operating income up 84%.
- Expense Reductions: Administrative expenses declined $6.4 million, driven by a $4.5 million drop in legal/environmental expenses and a $2.5 million reduction in severance costs compared to 2006.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items
- Gain on Sale: Recorded a $4.2 million pre-tax gain from the sale of the specialty ester surfactant product line to The HallStar Company in April 2007.
- Goodwill Impairment: Recorded a $3.5 million non-cash impairment charge related to the Stepan UK subsidiary in Q2 2007 due to lower than expected cash flow forecasts.
- Legal Settlements: Paid a $3.0 million settlement in Q1 2007 related to personal injury claims at a formerly owned site in Wilmington, Massachusetts (accrued in 2006).
Outlook and Management Commentary
- 2008 Capital Spending: Estimated at approximately $43.5 million.
- Market Conditions: Management notes that while the risk of recession in 2008 cannot be dismissed, the Company has opportunities to capitalize on existing plant capacity. Demand for agricultural products and fabric softeners is expected to remain strong.
- Raw Materials: Continued volatility in petroleum and natural gas prices remains a key factor; the Company continues to pass costs to customers where market conditions allow.
Risks and Contingencies
- Environmental Liabilities: The Company is a potentially responsible party at 23 waste disposal sites. Accrued liability for environmental and legal losses was $17.2 million at year-end, with a possible loss range of $10.1 million to $34.2 million.
- Debt Covenants: Loan agreements require maintenance of certain financial ratios and limit additional debt and dividends. The Company was in compliance as of December 31, 2007.
- Foreign Operations: Approximately 34% of sales are outside the U.S., exposing the Company to currency fluctuations and foreign regulatory risks.
Investor Verification Checklist
- Raw Material Pass-Through: Verify the Company's ability to sustain price increases in 2008 given competitive pressures and potential economic downturns.
- Environmental Reserves: Monitor updates on the Maywood, New Jersey site remediation and the range of potential losses ($10.1M - $34.2M) to ensure reserves remain adequate.
- Stepan UK Performance: Assess whether the Stepan UK subsidiary can recover from the goodwill impairment and achieve forecasted cash flows.
- Debt Maturity Profile: Review the $31 million in debt maturing in 2008 and the Company's liquidity position to ensure refinancing or repayment capability.
- Deferred Compensation Volatility: Note the impact of stock price fluctuations on deferred compensation expenses, though the Company adopted SFAS 159 in 2008 to mitigate some income statement volatility.